The application of high-throughput rnai in pancreatic cancer target discovery and drug development

Drug Discovery in Pancreatic Cancer: Models and Techniques

Volumn , Issue , 2010, Pages 153-170

  Yin, Hongwei ^a   Kiefer, Jeff ^a   Kassner, Michelle ^a   Tang, Nanyun ^a   Mousses, Spyro ^a  

^a TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84900092640     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-1160-5_8     Document Type: Chapter

References (43)

1. Bagga S, Bracht J, Hunter S et al (2005) Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell 122:553-563
2. Bartz SR, Zhang Z, Burchard J et al (2006) Small interfering RNA screens reveal enhanced cisplatin cytotoxicity in tumor cells having both BRCA network and TP53 disruptions. Mol Cell Biol 26:9377-9386
3. Berns K, Hijmans EM, Mullenders J et al (2004) A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 428:431-437
4. Bohnsack MT, Czaplinski K, Gorlich D (2004) Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. RNA 10:185-191
5. Boutros M, Ahringer J (2008) The art and design of genetic screens: RNA interference. Nat Rev Genet 9:554-566
6. Brummelkamp TR, Bernards R, Agami R (2002) Stable suppression of tumorigenicity by virusmediated RNA interference. Cancer Cell 2:243-247
7. Brummelkamp TR, Fabius AW, Mullenders J et al (2006) An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors. Nat Chem Biol 2:202-206
8. Caldwell JS (2007) Cancer cell-based genomic and small molecule screens. Adv Cancer Res 96:145-173
9. Ceyhan GO, Bergmann F, Kadihasanoglu M et al (2007) The neurotrophic factor artemin influences the extent of neural damage and growth in chronic pancreatitis. Gut 56:534-544
10. Dai H, Li R, Wheeler T et al (2007) Enhanced survival in perineural invasion of pancreatic cancer: an in vitro approach. Hum Pathol 38:299-307
11. Davis RE, Brown KD, Siebenlist U et al (2001) Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med 194:1861-1874
12. Duxbury MS, Ito H, Benoit E et al (2005) RNA interference demonstrates a novel role for integrinlinked kinase as a determinant of pancreatic adenocarcinoma cell gemcitabine chemoresistance. Clin Cancer Res 11:3433-3438
13. Echeverri CJ, Beachy PA, Baum B et al (2006) Minimizing the risk of reporting false positives in large-scale RNAi screens. Nat Methods 3:777-779
14. Echeverri CJ, Perrimon N (2006) High-throughput RNAi screening in cultured cells: a user's guide. Nat Rev Genet 7:373-384
15. Elbashir SM, Harborth J, Lendeckel W et al (2001a) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494-498
16. Elbashir SM, Lendeckel W, Tuschl T (2001b) RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 15:188-200
17. Fire A, Xu S, Montgomery MK et al (1998) Potent and specific genetic interference by doublestranded RNA in Caenorhabditis elegans. Nature 391:806-811
18. Giroux V, Iovanna J, Dagorn JC (2006) Probing the human kinome for kinases involved in pancreatic cancer cell survival and gemcitabine resistance. FASEB J 20:1982-1991
19. Hammond SM, Boettcher S, Caudy AA et al (2001) Argonaute2, a link between genetic and biochemical analyses of RNAi. Science 293:1146-1150
20. Iorns E, Lord CJ, Ashworth A (2009) Parallel RNAi and compound screens identify the PDK1 pathway as a target for tamoxifen sensitization. Biochem J 417:361-370
21. Iorns E, Lord CJ, Turner N et al (2007) Utilizing RNA interference to enhance cancer drug discovery. Nat Rev Drug Discov 6:556-568
22. Iorns E, Turner NC, Elliott R et al (2008) Identification of CDK10 as an important determinant of resistance to endocrine therapy for breast cancer. Cancer Cell 13:91-104
23. Jemal A, Siegel R, Ward E et al (2008) Cancer statistics, 2008. CA Cancer J Clin 58:71-96
24. Kennerdell JR, Carthew RW (1998) Use of dsRNA-mediated genetic interference to demonstrate that frizzled and frizzled 2 act in the wingless pathway. Cell 95:1017-1026
25. Kimmelman AC, Hezel AF, Aguirre AJ et al (2008) Genomic alterations link Rho family of GTPases to the highly invasive phenotype of pancreas cancer. Proc Natl Acad Sci USA 105:19372-19377
26. Konig R, Chiang CY, Tu BP et al (2007) A probability-based approach for the analysis of largescale RNAi screens. Nat Methods 4:847-849
27. Kuuselo R, Savinainen K, Azorsa DO et al (2007) Intersex-like (IXL) is a cell survival regulator in pancreatic cancer with 19q13 amplification. Cancer Res 67:1943-1949
28. Lord CJ, McDonald S, Swift S et al (2008) A high-throughput RNA interference screen for DNA repair determinants of PARP inhibitor sensitivity. DNA Repair (Amst) 7:2010-2019
29. Lund E, Guttinger S, Calado A et al (2004) Nuclear export of microRNA precursors. Science 303:95-98
30. MacKeigan JP, Murphy LO, Blenis J (2005) Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance. Nat Cell Biol 7:591-600
31. Misquitta L, Paterson BM (1999) Targeted disruption of gene function in Drosophila by RNA interference (RNA-i): a role for nautilus in embryonic somatic muscle formation. Proc Natl Acad Sci USA 96:1451-1456
32. Morgan-Lappe S, Woods KW, Li Q et al (2006) RNAi-based screening of the human kinome identifies Akt-cooperating kinases: a new approach to designing efficacious multitargeted kinase inhibitors. Oncogene 25:1340-1348
33. Morgan MA, Parsels LA, Parsels JD et al (2005) Role of checkpoint kinase 1 in preventing premature mitosis in response to gemcitabine. Cancer Res 65:6835-6842
34. Ngo VN, Davis RE, Lamy L et al (2006) A loss-of-function RNA interference screen for molecular targets in cancer. Nature 441:106-110
35. Paddison PJ, Caudy AA, Sachidanandam R et al (2004a) Short hairpin activated gene silencing in mammalian cells. Methods Mol Biol 265:85-100
36. Paddison PJ, Silva JM, Conklin DS et al (2004b) A resource for large-scale RNA-interferencebased screens in mammals. Nature 428:427-431
37. Perrimon N, Friedman A, Mathey-Prevot B et al (2007) Drug-target identification in Drosophila cells: combining high-throughout RNAi and small-molecule screens. Drug Discov Today 12:28-33
38. Pillai RS, Bhattacharyya SN, Artus CG et al (2005) Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science 309:1573-1576
39. Schlabach MR, Luo J, Solimini NL et al (2008) Cancer proliferation gene discovery through functional genomics. Science 319:620-624
40. Turner NC, Lord CJ, Iorns E et al (2008) A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor. EMBO J 27:1368-1377
41. Wang H, Han H, Von Hoff DD (2006) Identification of an agent selectively targeting DPC4 (deleted in pancreatic cancer locus 4)-deficient pancreatic cancer cells. Cancer Res 66:9722-9730
42. Whitehurst AW, Bodemann BO, Cardenas J et al (2007) Synthetic lethal screen identification of chemosensitizer loci in cancer cells. Nature 446:815-819
43. Yu JY, De Ruiter SL, Turner DL (2002) RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci USA 99:6047-6052